Jushi Holdings (JUSHF) EBITDA Margin Growth (1y) (2022 - 2026)
Jushi Holdings (JUSHF) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | -454.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -454.00 |
| Mar 31, 2026 | 531.00 |
| Dec 31, 2025 | 394.00 |
| Sep 30, 2025 | 327.00 |
| Jun 30, 2025 | -747.00 |
| Mar 31, 2025 | -922.00 |
| Dec 31, 2024 | 685.00 |
| Sep 30, 2024 | -403.00 |
| Jun 30, 2024 | 789.00 |
| Mar 31, 2024 | 989.00 |
| Dec 31, 2023 | 17,157.00 |
| Sep 30, 2023 | 7,360.00 |
| Jun 30, 2023 | 2,172.00 |
| Mar 31, 2023 | 2,581.00 |
| Dec 31, 2022 | -14,170.00 |
| Sep 30, 2022 | -6,590.00 |
| Jun 30, 2022 | -667.00 |